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Patients with symptoms suggestive of acute myocardial infarction (AMI) ac-count for ≈10% of all emergency department (ED) presentations.1 The ma-jority of patients are finally found to have diagnoses other than AMI.2 Thus, 
the expeditious evaluation of such patients is important because delays in ruling 
out AMI may interfere with the detection of other underlying diseases. The 0/1 
hour (0/1h) algorithm and the 0/3 hour (0/3h) algorithm are both recommended 
by the European Society of Cardiology with a Class I recommendation for the 
early rule-out of AMI.1 The 0/1h algorithm and 0/3h algorithm are completely 
different protocols. Whereas the 0/1h algorithm uses high-sensitivity cardiac tro-
ponin (hs-cTn) concentrations at presentation and absolute changes within the 
first hour and hence takes optimal advantage of the increased diagnostic ac-
curacy and precision of hs-cTn assays, the 0/3h algorithm uses a fixed threshold 
protocol based on the 99th percentile at presentation and 3 hours in conjunction 
with clinical criteria (GRACE [Global Registry of Acute Coronary Events] score 
<140 and the need to be pain free). It is currently unknown whether 1 algorithm 
is preferable to the other.
The aim of this study was to directly compare safety, quantified by the negative 
predictive value (NPV) and the negative likelihood ratio (LR) for the presence of AMI, 
and efficacy, quantified by the proportion of patients triaged toward rule-out in a 
large diagnostic multicenter study enrolling patients presenting with suspected AMI 
to the ED (URL: https://www.clinicaltrials.gov. Unique identifier: NCT00470587). 
The study was carried out according to the principles of the Declaration of Helsinki 
and approved by the local ethics committees. Written informed consent was ob-
tained from all patients. Patients presenting with ST-segment–elevation MI were 
excluded. Triage toward rule-out by the 0/1h or the 0/3h algorithm was compared 
against the final adjudication performed by 2 independent cardiologists using all 
information, including cardiac imaging and serial hs-cTnT measurements. Analyses 
were performed with hs-cTnT and hs-cTnI. NPV and efficacy were compared by 
the McNemar test and Pearson χ2 test, respectively. The 95% confidence intervals 
(CIs) were calculated with the Wilson score method without continuity correction.
Among 2547 patients eligible for analysis with hs-cTnT, AMI was the final ad-
judicated diagnosis in 387 patients (15%). The 0/1h algorithm provided safety 
similar to that of the 0/3h algorithm (NPV, 99.8% [95% CI, 99.4–99.9] and nega-
tive LR, 0.01 [95% CI, 0.00–0.03] versus NPV, 99.7% [95% CI, 99.2–99.9] and 
negative LR, 0.02 [95% CI, 0.00–0.05]) but allowed the rule-out of significantly 
more patients compared with the 0/3h algorithm (60% versus 44%; P<0.001). 
Among 2197 patients eligible for analysis with hs-cTnI, AMI was the final diagnosis 
in 327 patients (15%). The 0/1h algorithm provided higher safety compared with 
the 0/3h algorithm (NPV, 99.6% [95% CI, 99.1–99.9%] and negative LR, 0.02 
[95% CI, 0.01–0.05] versus NPV, 97.8% [95% CI, 96.7–98.5] and negative LR, 
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0.13 [95% CI, 0.09–0.19]) and allowed the rule-out of 
a similar portion of patients compared with the 0/3h-
algorithm (52% versus 51%; P=0.507; Figure).
Overall, 711 patients (28%) presented within the 
first 2 hours from chest pain onset. Safety for the 0/1h 
and 0/3h algorithms with hs-cTnT was very high (NPV, 
99.6% [95% CI, 98.4–99.9] versus 100% [95% CI, 
98.9–100]) and comparable to late presenters (chest 
pain onset >2 hours) with 99.9% (95% CI, 99.5–100) 
versus 99.6% (95% CI, 98.9–99.9), respectively. The 
0/1h algorithm allowed the rule-out of more patients 
compared with the 0/3h algorithm in early present-
ers (64% versus 49%; P<0.001) and in late presenters 
(59% versus 42%; P<0.001). Findings were confirmed 
with hs-cTnI and with 30-day survival used as an ad-
ditional outcome measure for safety, with survival rates 
of 99.9% to 100% for patients triaged toward rule-out 
by both algorithms.
These findings corroborate and extend previous 
work on the development and validation of safe and 
effective rule-out strategies for AMI and have im-
portant clinical implications.3–5 The excellent safety 
achieved with both algorithms documents the suitabil-
ity of most of these patients for early discharge and 
outpatient management. Beyond the more favorable 
combination of safety and efficacy by the 0/1h algo-
rithm versus the 0/3h algorithm, the following features 
may help physicians and institutions in the selection of 
their preferred triage algorithm. First, the 0/1h algo-
rithm has the obvious and important additional advan-
tage of allowing clinical decision making 2 hours ear-
lier compared with the 0/3h algorithm. Because most 
patients triaged toward early rule-out are also candi-
dates for direct discharge from the ED, it is very likely 
that it will reduce time to discharge and treatment cost 
in the ED. Second, the 0/1h algorithm does not require 
the use of a specific risk score, which further increases 
its feasibility. Previous studies have documented that 
omitting any of the 3 elements of the 0/3h algorithm 
(hs-cTn, GRACE score, pain-free criterion) in an effort 
to simplify the approach would worsen its safety and 
is therefore discouraged. Third, when putting our find-
ings into clinical perspective, it is important to high-
light that the 0/1h algorithm and the 0/3h algorithm 
should always be used in conjunction with all clinical 
information available. This is of paramount importance 
because, among patients presenting with acute chest 
discomfort to the ED, the rule-out of AMI is related to 
the possibility of rapid discharge and outpatient man-
agement but not identical to it.
In conclusion, the 0/1h algorithm is superior to the 
0/3h algorithm using hs-cTnT as well as hs-cTnI because 
it more favorably combines safety with efficacy.
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Figure. Direct comparison of the 
0/1h and 0/3h algorithms for 
early rule-out of AMI using hs-
cTnT (A) and hs-cTnI (B). 
The figure illustrates both coprimary 
end points: safety, as quantified by 
the negative predictive value (NPV; 
percent), and efficacy (proportion 
of patients assigned to ruled out; 
percent). Bars represent 95% confi-
dence intervals. AMI indicates acute 
myocardial infarction; and hs-cTn, 
high-sensitivity cardiac troponin.
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APPENDIX
Additional APACE Investigators: Zaid Sabti; Ivo Strebel; Samyut Shrestha; Day-
ana Flores; Michael Freese; Claudia Stelzig; Caroline Kulangara; Kathrin Meiss-
ner; Nicolas Schaerli; Deborah Mueller; Ana Yufera Sanchez; Lorraine Sazgary; 
Stella Marbot; Carolina Fuenzalida; Sofia Calderón; Esther Rodriguez Adrada; 
Damian Kawecki; Ewa Nowalany-Kozielska; Jiri Parenica; Eva Ganovská; Arnold 
von Eckardstein; Jens Lohrmann; Wanda Kloos; Stefan Osswald; Andreas Buser; 
Roland Bingisser; Nicolas Geigy.
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